Nexinhib20   Click here for help

GtoPdb Ligand ID: 9419

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: We have interpreted the image from [2] as the Z form. Note there is also the E form as PubChem CID: 5759185 and a unresolved entry as PubChem CID: 2817394. Note this is an old compound (2005) from the Molecular Libraries screening collection and has many bioassay results (see ChEMBL entries) that were not assessed by the authors, so circumspection concerning pharmacological specificity is warranted.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 90.92
Molecular weight 300.12
XLogP 2.42
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(C(C)(C)C)C(=Cc1cccc(c1)[N+](=O)[O-])n1cncn1
Isomeric SMILES O=C(C(C)(C)C)/C(=C/c1cccc(c1)[N+](=O)[O-])/n1cncn1
InChI InChI=1S/C15H16N4O3/c1-15(2,3)14(20)13(18-10-16-9-17-18)8-11-5-4-6-12(7-11)19(21)22/h4-10H,1-3H3/b13-8-
InChI Key VKSOIYNNOFGGES-JYRVWZFOSA-N
Immunopharmacology Comments
Nexinhib20 was developed in the search for novel small molecule inhibitors of neutrophil exocytosis and inflammation, targeting RAB27A a central regulator of neutrophil exocytosis [1].